医学
肥胖
超重
糖尿病
医疗保健
卫生专业人员
肥胖管理
家庭医学
替代医学
梅德林
物理疗法
老年学
重症监护医学
减肥
2型糖尿病
公共卫生
联想(心理学)
环境卫生
标识
DOI:10.1136/bmjdrc-2025-005729
摘要
Obesity medications may be part of a comprehensive care plan for adults with obesity. The Obesity Association, a division of the American Diabetes Association (ADA), developed comprehensive, evidence-based guidelines on the pharmacologic treatment of obesity in adults. When used in conjunction with lifestyle modifications, obesity medications have demonstrated efficacy in inducing and sustaining weight reduction while concurrently improving clinical outcomes of obesity and obesity-related diseases and complications. Healthcare professionals should engage people with obesity in a person-centered, shared decision-making approach when selecting an obesity medication to optimize health outcomes while emphasizing individual needs and preferences. The ADA’s Obesity Association encourages healthcare professionals to adopt these guidelines for treatment of obesity in adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI